Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Capital Expenditures: 2019-2025

Historic Capital Expenditures for Harmony Biosciences Holdings (HRMY) over the last 4 years, with Sep 2025 value amounting to $71,000.

  • Harmony Biosciences Holdings' Capital Expenditures rose 2266.67% to $71,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $716,000, marking a year-over-year decrease of 4.15%. This contributed to the annual value of $1.2 million for FY2024, which is 269.55% up from last year.
  • Per Harmony Biosciences Holdings' latest filing, its Capital Expenditures stood at $71,000 for Q3 2025, which was up 1,675.00% from $4,000 recorded in Q2 2025.
  • Over the past 5 years, Harmony Biosciences Holdings' Capital Expenditures peaked at $632,000 during Q2 2024, and registered a low of $3,000 during Q3 2024.
  • Over the past 3 years, Harmony Biosciences Holdings' median Capital Expenditures value was $89,000 (recorded in 2023), while the average stood at $182,875.
  • Data for Harmony Biosciences Holdings' Capital Expenditures shows a peak YoY increase of 2,460.00% (in 2025) and a maximum YoY decrease of 99.37% (in 2025) over the last 5 years.
  • Over the past 5 years, Harmony Biosciences Holdings' Capital Expenditures (Quarterly) stood at $93,000 in 2021, then declined by 7.53% to $86,000 in 2022, then reached $107,000 in 2023, then spiked by 379.44% to $513,000 in 2024, then spiked by 2,266.67% to $71,000 in 2025.
  • Its last three reported values are $71,000 in Q3 2025, $4,000 for Q2 2025, and $128,000 during Q1 2025.